(1888PressRelease)
June 10, 2009 - Shipment of the product will be phased over the remainder of the fiscal year 2010 with the first shipment likely to commence in early Q2 of fiscal year 2010.
Omeprazole Mg is indicated for the treatment of heartburn. Dr. Reddy’s formulation contains 20.6mg Omeprazole Mg and the dosage form is a capsule.
About Dr. Reddy’s
Established in 1984, Dr. Reddy’s Laboratories (NYSE: RDY) is an emerging global pharmaceutical company whose purpose is providing affordable and innovative medicines for healthier lives. Dr. Reddy’s is vertically integrated with a presence across the pharmaceutical value chain through its core businesses of Global Generics, Pharmaceutical Services & Active Ingredients (PSAI), and Proprietary Products, which includes New Chemical Entities, Generic Biopharmaceuticals and Differentiated formulations. The company’s products are marketed globally, with a focus on India, US, Europe and Russia.
For more information please see: www.drreddys.com
Contact Information
Investors and Financial Analysts:
Kedar Upadhye at kedaru ( @ ) drreddys dot com /+91-40-66834297
Raghavender R at raghavenderr ( @ ) drreddys dot com /+91-40-66511529
Milan Kalawadia (North America) at mkalawadia ( @ ) drreddys dot com or at 908-203-4931
Media
Mythili M at mythilim ( @ ) drreddys dot com or on +91-40-66511620
Rajan S at rajans ( @ ) drreddys dot com / +91-40- 66511725
###
